Dr. Reddys Laboratories is currently trading at Rs. 1996.80, up by 47.85 points or 2.46% from its previous closing of Rs. 1948.95 on the BSE.

The scrip opened at Rs. 1910.10 and has touched a high and low of Rs. 2018.00 and Rs. 1901.65 respectively. So far 69617 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3394.95 on 28-Oct-2016 and a 52 week low of Rs. 1935.05 on 10-Aug-2017.

Last one week high and low of the scrip stood at Rs. 2327.90 and Rs. 1935.05 respectively. The current market cap of the company is Rs. 33345.72 crore.

The promoters holding in the company stood at 26.78%, while institutions and non-institutions held 43.38% and 13.68% respectively.

Dr. Reddy’s Laboratories’ wholly-owned subsidiary -- betapharm Arzneimittel GmbH, Germany has received a communication from the Regulatory Authority of Germany (Regierung von Oberbayern), that the GMP compliance certificate in respect of the company’s Formulations Manufacturing Unit 2 plant in Bachupally, Hyderabad is not renewed consequent to the recent inspection of the plant. Pending revocation of the non-compliance notification, the plant will not be able to make any further despatch to the European Union until the next inspection, to be initiated by an invitation from betapharm.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1218.40 9.95 (0.82%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×